These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 32271689

  • 1. 3-Year Followup of a New Implantable Tibial Nerve Stimulator for the Treatment of Overactive Bladder Syndrome.
    Dorsthorst MJT, Digesu GA, Tailor V, Gore M, van Kerrebroeck PE, van Breda HMK, Elneil S, Heesakkers JPFA.
    J Urol; 2020 Sep; 204(3):545-550. PubMed ID: 32271689
    [Abstract] [Full Text] [Related]

  • 2. A novel leadless, miniature implantable Tibial Nerve Neuromodulation System for the management of overactive bladder complaints.
    Heesakkers JPFA, Digesu GA, van Breda J, Van Kerrebroeck P, Elneil S.
    Neurourol Urodyn; 2018 Mar; 37(3):1060-1067. PubMed ID: 28892221
    [Abstract] [Full Text] [Related]

  • 3. A New Implanted Posterior Tibial Nerve Stimulator for the Treatment of Overactive Bladder Syndrome: 3-Month Results of a Novel Therapy at a Single Center.
    van Breda HMK, Martens FMJ, Tromp J, Heesakkers JPFA.
    J Urol; 2017 Jul; 198(1):205-210. PubMed ID: 28189576
    [Abstract] [Full Text] [Related]

  • 4. A prospective study to assess the effectiveness and safety of the BlueWind System in the treatment of patients diagnosed with urgency urinary incontinence.
    Heesakkers JPFA, Toozs-Hobson P, Sutherland SE, Digesu A, Amundsen CL, McCrery RJ, De Wachter S, Kean ER, Martens F, Benson K, Ferrante KL, Cline KJ, Padron OF, Giusto L, Lane FL, Dmochowski RR.
    Neurourol Urodyn; 2024 Sep; 43(7):1491-1503. PubMed ID: 38634481
    [Abstract] [Full Text] [Related]

  • 5. Percutaneous tibial nerve stimulation for the long-term treatment of overactive bladder: 3-year results of the STEP study.
    Peters KM, Carrico DJ, Wooldridge LS, Miller CJ, MacDiarmid SA.
    J Urol; 2013 Jun; 189(6):2194-201. PubMed ID: 23219541
    [Abstract] [Full Text] [Related]

  • 6. Five-Year Followup Results of a Prospective, Multicenter Study of Patients with Overactive Bladder Treated with Sacral Neuromodulation.
    Siegel S, Noblett K, Mangel J, Bennett J, Griebling TL, Sutherland SE, Bird ET, Comiter C, Culkin D, Zylstra S, Kan F, Berg KC.
    J Urol; 2018 Jan; 199(1):229-236. PubMed ID: 28709886
    [Abstract] [Full Text] [Related]

  • 7. Twelve-month Durability of a Fully-implanted, Nickel-sized and Shaped Tibial Nerve Stimulator for the Treatment of Overactive Bladder Syndrome with Urgency Urinary Incontinence: A Single-Arm, Prospective Study.
    Gilling P, Meffan P, Kaaki B, MacDiarmid S, Lucente V, Clark M, Sen SK, English S, Sand PK.
    Urology; 2021 Nov; 157():71-78. PubMed ID: 34048826
    [Abstract] [Full Text] [Related]

  • 8. Randomized trial of percutaneous tibial nerve stimulation versus Sham efficacy in the treatment of overactive bladder syndrome: results from the SUmiT trial.
    Peters KM, Carrico DJ, Perez-Marrero RA, Khan AU, Wooldridge LS, Davis GL, Macdiarmid SA.
    J Urol; 2010 Apr; 183(4):1438-43. PubMed ID: 20171677
    [Abstract] [Full Text] [Related]

  • 9. Long-term durability of percutaneous tibial nerve stimulation for the treatment of overactive bladder.
    MacDiarmid SA, Peters KM, Shobeiri SA, Wooldridge LS, Rovner ES, Leong FC, Siegel SW, Tate SB, Feagins BA.
    J Urol; 2010 Jan; 183(1):234-40. PubMed ID: 19913821
    [Abstract] [Full Text] [Related]

  • 10. Review of New Implantable Tibial Nerve Stimulators in Comparison to Established Third Line Treatment Modalities for Nonneurogenic Overactive Bladder.
    Tipton WA, de Riese WTW, de Riese CS.
    Urol Pract; 2020 Nov; 7(6):530-537. PubMed ID: 37287172
    [Abstract] [Full Text] [Related]

  • 11. Feasibility of a Fully Implanted, Nickel Sized and Shaped Tibial Nerve Stimulator for the Treatment of Overactive Bladder Syndrome with Urgency Urinary Incontinence.
    MacDiarmid S, Staskin DR, Lucente V, Kaaki B, English S, Gilling P, Meffan P, Clark M, Sand PK, Sen SK, Rovner E.
    J Urol; 2019 May; 201(5):967-972. PubMed ID: 31009968
    [Abstract] [Full Text] [Related]

  • 12. Update on Implantable PTNS Devices.
    Vollstedt A, Gilleran J.
    Curr Urol Rep; 2020 May 28; 21(7):28. PubMed ID: 32462381
    [Abstract] [Full Text] [Related]

  • 13. Randomized trial of percutaneous tibial nerve stimulation versus extended-release tolterodine: results from the overactive bladder innovative therapy trial.
    Peters KM, Macdiarmid SA, Wooldridge LS, Leong FC, Shobeiri SA, Rovner ES, Siegel SW, Tate SB, Jarnagin BK, Rosenblatt PL, Feagins BA.
    J Urol; 2009 Sep 28; 182(3):1055-61. PubMed ID: 19616802
    [Abstract] [Full Text] [Related]

  • 14. Urgent-SQ implant in treatment of overactive bladder syndrome: 9-year follow-up study.
    Janssen DA, Farag F, Heesakkers JP.
    Neurourol Urodyn; 2013 Jun 28; 32(5):472-5. PubMed ID: 23070697
    [Abstract] [Full Text] [Related]

  • 15. A prospective, multicenter study of a novel, miniaturized rechargeable sacral neuromodulation system: 12-month results from the RELAX-OAB study.
    Blok B, Van Kerrebroeck P, de Wachter S, Ruffion A, Van der Aa F, Jairam R, Perrouin-Verbe MA, Elneil S.
    Neurourol Urodyn; 2019 Feb 28; 38(2):689-695. PubMed ID: 30592526
    [Abstract] [Full Text] [Related]

  • 16. A Prospective Study to Evaluate Efficacy Using the Nuro Percutaneous Tibial Neuromodulation System in Drug-Naïve Patients With Overactive Bladder Syndrome.
    Kobashi K, Nitti V, Margolis E, Sand P, Siegel S, Khandwala S, Newman D, MacDiarmid SA, Kan F, Michaud E.
    Urology; 2019 Sep 28; 131():77-82. PubMed ID: 31199966
    [Abstract] [Full Text] [Related]

  • 17. Sustained therapeutic effects of percutaneous tibial nerve stimulation: 24-month results of the STEP study.
    Peters KM, Carrico DJ, MacDiarmid SA, Wooldridge LS, Khan AU, McCoy CE, Franco N, Bennett JB.
    Neurourol Urodyn; 2013 Jan 28; 32(1):24-9. PubMed ID: 22674493
    [Abstract] [Full Text] [Related]

  • 18. Three-year Follow-up Results of a Prospective, Multicenter Study in Overactive Bladder Subjects Treated With Sacral Neuromodulation.
    Siegel S, Noblett K, Mangel J, Griebling TL, Sutherland SE, Bird ET, Comiter C, Culkin D, Bennett J, Zylstra S, Kan F, Thiery E.
    Urology; 2016 Aug 28; 94():57-63. PubMed ID: 27131966
    [Abstract] [Full Text] [Related]

  • 19. Posterior tibial nerve stimulation vs parasacral transcutaneous neuromodulation for overactive bladder in children.
    Barroso U, Viterbo W, Bittencourt J, Farias T, Lordêlo P.
    J Urol; 2013 Aug 28; 190(2):673-7. PubMed ID: 23422257
    [Abstract] [Full Text] [Related]

  • 20. Durable Efficacy and Safety of Long-Term OnabotulinumtoxinA Treatment in Patients with Overactive Bladder Syndrome: Final Results of a 3.5-Year Study.
    Nitti VW, Ginsberg D, Sievert KD, Sussman D, Radomski S, Sand P, De Ridder D, Jenkins B, Magyar A, Chapple C, 191622-096 Investigators.
    J Urol; 2016 Sep 28; 196(3):791-800. PubMed ID: 27038769
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.